Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Thymosin Alpha-1 An immune-modulating peptide approved as a pharmaceutical product in more than 30 countries for applications including hepatitis B, hepatitis C, and immune adjuvant therapy in oncology
FAQ: Can BPC-157 Influence Tight Junction Proteins and Intestinal Barrier Integrity
Weight on the scale might drop 2-4 pounds (depending on starting point and deficit)
Jul 2014;100(1):27-35
Potential Benefits & Side Effects Observations from phase 2 and phase 3 clinical trials
BPC-157 TB-500 Side Effects & Safety BPC-157 Generally very well tolerated in research models Minimal reported side effects at standard doses No significant hormonal impact Theoretical concern: may promote angiogenesis in existing tumors (same as any pro-angiogenic compound) TB-500 Well tolerated
